Vimarsana
Biggest News Aggregation in the World

Page 8 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea - Vimarsana News

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics - Vimarsana News

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

Researchers introduce new approach for accurately assessing cell composition in the pancreas - Vimarsana News

Researchers introduce new approach for accurately assessing cell composition in the pancreas

Research introduces new DNA methylation-based method for accurately assessing cell composition in the human pancreas, addressing a critical gap in diabetes research.

LJI scientists uncover clues to how human T cells combat Mycobacterium tuberculosis - Vimarsana News

LJI scientists uncover clues to how human T cells combat Mycobacterium tuberculosis

La Jolla Institute for Immunology (LJI) is working to guide the development of new tuberculosis vaccines and drug therapies.

Decoding Hologic Inc (HOLX): A Strategic SWOT Insight - Vimarsana News

Decoding Hologic Inc (HOLX): A Strategic SWOT Insight

Unveiling the Strengths and Challenges: A Deep Dive into Hologic Inc (HOLX) SWOT Analysis

Source: yahoo.com